AP NEWS

Global Interferons Market 2019-2023 | Advent of Biosimilars to Boost Growth | Technavio

February 13, 2019
Technavio has released a new market research report on the global interferons market for the period 2019-2023. (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--Feb 13, 2019--The global interferons market is expected to post a CAGR of close to 2% during the period 2019-2023, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190213005712/en/

Technavio has released a new market research report on the global interferons market for the period 2019-2023. (Graphic: Business Wire)

Interferons are mostly administered through the intravenous RoA, which is associated with many side effects such as redness, irritation, swelling at the injection site, and it also directly increases the risk of extravasation. Hence, there is an increased focus on the development of novel drug delivery systems for interferons that can provide maximum benefit with a minimum dose. Delivery mechanisms are being designed to deliver interferons to the target site for improved treatment efficacy. Therefore, with such initiatives, the market is expected to grow further during the forecast period.

As per Technavio, the advent of biosimilars will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global interferons market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Global interferons market: Advent of biosimilars

The growing demand for quality care has led to the increased use of biologics owing to their higher efficacy and lesser side effects compared with small molecule drugs. However, the high cost of biologics is a concern. Biosimilars are likely to play a prominent role in this respect as they have identical active pharmaceutical ingredients to their originator biologic compounds but are cheaper than the biologics, thereby increasing their accessibility. A biosimilar is a copy of the biologic that has been already authorized for use and is found to cost 20%-25% lesser than the originator biologic. As the global interferons market is expected to continue witnessing a patent cliff during the forecast period the advent of these biosimilars will fuel market growth.

“Apart from the advent of biosimilars, the high target affinity and specificity of interferons and the expansion of application are some other major aspects that are expected to boost the growth of the global interferons market during the forecast period,” says a senior analyst at Technavio.

Global interferons market: Segmentation analysis

This market research report segments the global interferons market by type (interferon beta, interferon alfa, and other interferons) and geographical regions (North America, Europe, Asia, ROW).

The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. However, during the forecast period, the Asian region is expected to register the highest incremental growth due to the developing healthcare segment in the region combined with the presence of a large population base.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190213005712/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 02/13/2019 02:02 PM/DISC: 02/13/2019 02:02 PM

http://www.businesswire.com/news/home/20190213005712/en

AP RADIO
Update hourly